Baynes Roy D. bought TVTX
April 6, 2026 · Form 4 insider transaction
Baynes Roy D. bought 10,000 shares of Travere Therapeutics, Inc. at $26.52 per share, a transaction worth $265.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$26.52
Total value
$265.2K
InsiderBaynes Roy D.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 6, 2026
Filing dateApril 7, 2026
Shares owned after47,500
OwnershipDirect
10b5-1 planNo
AmendedNo